Ken Griffin Spectrum Pharmaceuticals Inc Put Options Transaction History

Citadel Advisors LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2023 Aug 14, 2023	SELL	$0.65 - $1.31 $1,235 - $2,489	-1,900 Reduced 67.86%	900 $0
Q1 2023 May 15, 2023	SELL	$0.38 - $1.07 $4,598 - $12,947	-12,100 Reduced 81.21%	2,800 $2,000
Q4 2022 Feb 14, 2023	SELL	$0.32 - $0.52 $15,584 - $25,324	-48,700 Reduced 76.57%	14,900 $5,000
Q3 2022 Nov 14, 2022	BUY	$0.43 - $1.56 $27,348 - $99,216	63,600 New	63,600 $27,000

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.